| Drug Name: | Modified Release Dipyridamole |
|---|
| Drug Class: | Antiplatelet Agent |
|---|
| Mechanism of Action: | - Inhibits platelet aggregation by blocking adenosine uptake and phosphodiesterase activity
- Increases cAMP levels in platelets, leading to inhibition of platelet activation and aggregation
|
|---|
| Use: | - Prevention of stroke and systemic embolism in patients with a history of transient ischemic attack or ischemic stroke
- Adjunctive therapy with aspirin to reduce the risk of recurrent stroke
|
|---|
| Side Effects: | - Headache
- Dizziness
- Abdominal pain
- Nausea
- Diarrhea
- Flushing
- Hypotension
- Bleeding
|
|---|
| Contraindications: | - Hypersensitivity to dipyridamole or any component of the formulation
- Active bleeding
- Severe coronary artery disease
- Hypotension
- Asthma
|
|---|
| Specialty: | |
|---|